Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis.

Abu-Shakra M, Zisman D, Balbir-Gurman A, Amital H, Levy Y, Langevitz P, Tishler M, Molad Y, Aamar S, Roser I, Avshovich N, Paran D, Reitblat T, Mader R, Savin H, Friedman J, Lieberman N, Ehrlich S.

Isr Med Assoc J. 2018 Apr;20(4):239-244.

2.

Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis.

Barrett O, Abramovich E, Dreiher J, Novack V, Abu-Shakra M.

Rheumatol Int. 2017 Jun;37(6):1021-1026. doi: 10.1007/s00296-017-3694-5. Epub 2017 Mar 12.

PMID:
28286904
3.

Prediction of Antiphospholipid syndrome using Annexin A5 competition assay in patients with SLE.

Avriel A, Fleischer S, Friger M, Shovman O, Neuman G, Shoenfeld Y, Abu-Shakra M.

Clin Rheumatol. 2016 Dec;35(12):2933-2938. Epub 2016 Oct 4.

PMID:
27704312
4.

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.

Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group.

Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856.

5.

Quality of Life, Coping and Depression in Systemic Lupus Erythematosus.

Abu-Shakra M.

Isr Med Assoc J. 2016 Mar-Apr;18(3-4):144-5.

6.

[TREATMENT DILEMMAS IN BEHÇET'S SYNDROME].

Zeller L, Ling E, Abu-Shakra M.

Harefuah. 2016 Feb;155(2):92-3, 132-3. Hebrew.

PMID:
27215119
7.

Assessment of aortic stiffness among patients with systemic lupus erythematosus and rheumatoid arthritis by magnetic resonance imaging.

Karp G, Wolak A, Baumfeld Y, Bar-Am N, Novack V, Wolak T, Fuchs L, Shalev A, Shelef I, Abu-Shakra M.

Int J Cardiovasc Imaging. 2016 Jun;32(6):935-44. doi: 10.1007/s10554-016-0851-y. Epub 2016 Feb 6.

PMID:
26852242
8.

To the Editor.

Zeller L, Abu-Shakra M.

Isr Med Assoc J. 2015 Oct;17(10):660. No abstract available.

9.

Pulmonary Granulomatous Inflammation in Systemic Lupus Erythematosus.

Avnon LS, Smoliakov A, Sinelko I, Abu-Shakra M.

Isr Med Assoc J. 2015 Oct;17(10):650-2. No abstract available.

10.

Acute Myocarditis and Myopathy as Presenting Manifestations of Human Immunodeficiency Virus Infection.

Kiselnik D, Wolak A, Abu-Shakra M, Basok A.

Isr Med Assoc J. 2015 Aug;17(8):524-5. No abstract available.

11.

Taenia solium in a patient with systemic lupus erythematosus: do parasites protect against autoimmune diseases.

Zeller L, Barski L, Shleyfer E, Netz U, Stavi V, Abu-Shakra M.

Isr Med Assoc J. 2015 Apr;17(4):259-60. No abstract available.

12.

Mortality due to sepsis in patients with systemic lupus erythematosus and rheumatoid arthritis.

Barrett O, Abramovich E, Dreiher J, Novack V, Abu-Shakra M.

Isr Med Assoc J. 2014 Oct;16(10):634-5. No abstract available.

13.

Dead Sea mud packs for chronic low back pain.

Abu-Shakra M, Mayer A, Friger M, Harari M.

Isr Med Assoc J. 2014 Sep;16(9):574-7.

14.

Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study.

Wolak T, Aliev E, Rogachev B, Baumfeld Y, Cafri C, Abu-Shakra M, Novack V.

Isr Med Assoc J. 2013 Nov;15(11):682-7.

15.

Tocilizumab in adult-onset Still's disease: the Israeli experience.

Elkayam O, Jiries N, Dranitzki Z, Kivity S, Lidar M, Levy O, Ablin J, Abu-Shakra M, Savargyl-Maman H, Padova H, Caspi D, Rosner I.

J Rheumatol. 2014 Feb;41(2):244-7. doi: 10.3899/jrheum.130881. Epub 2014 Jan 15.

PMID:
24429168
16.

Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".

Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE, Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G; Catastrophic Registry Project Group (European Forum on Antiphospholipid Antibodies).

Autoimmun Rev. 2014 Feb;13(2):157-62. doi: 10.1016/j.autrev.2013.10.004. Epub 2013 Oct 19.

PMID:
24145009
17.
18.

Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 website.

Touma Z, Gladman DD, MacKinnon A, Carette S, Abu-Shakra M, Askanase A, Nived O, Hanly JG, Landolt-Marticorena C, Tam LS, Toloza S, Nikpour M, Riddell C, Steiman A, Eder L, Haddad A, Barber C, Urowitz MB.

J Rheumatol. 2013 Jan;40(1):34-9. doi: 10.3899/jrheum.120754. Epub 2012 Nov 1.

PMID:
23118108
19.

Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.

Espinosa G, Rodríguez-Pintó I, Gomez-Puerta JA, Pons-Estel G, Cervera R; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies).

Semin Arthritis Rheum. 2013 Feb;42(4):417-23. doi: 10.1016/j.semarthrit.2012.05.005. Epub 2012 Jul 10.

PMID:
22784445
20.

Mortality and multiple causes of death in systemic lupus erythematosus -- role of the death certificate.

Abu-Shakra M, Novack V.

J Rheumatol. 2012 Mar;39(3):458-60. doi: 10.3899/jrheum.111556. No abstract available.

PMID:
22383351

Supplemental Content

Loading ...
Support Center